ATP hydrolysis by a CFTR domain: Pharmacology and effects of G551D mutation

Biochemical and Biophysical Research Communications

Volumn 271, Issue 2, 2000, Pages 518-525

  Howell, L Daniel ^a   Borchardt, Roy ^a   Cohn, Jonathan A ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

8 Cyclopentyl 1,3 dipropylxanthine; ABC transporter; ATP hydrolase; Flavonol; Vanadate

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE INHIBITOR; ADENOSINE TRIPHOSPHATE; CHLORIDE CHANNEL; GENISTEIN; GLIBENCLAMIDE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CYSTIC FIBROSIS; GENE MUTATION; HUMAN; HYDROLYSIS; PRIORITY JOURNAL;

EID: 0034630742     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2659     Document Type: Article

References (53)

1. Riordan, J. R., Rommens, J. M., Kerem, B. S., Alon., N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J. L., Dramm, M. L., Iannuzzi, M. C., Collins, F. S., and Tsui, L-C. (1989) Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245, 1066-1073.
2. Neville, D. C., Rozanas, C. R., Tulk, B. M., Townsend, R. R., and Verkman, A. S. (1998) Expression and characterization of the NBD1-R domain region of CFTR: Evidence for subunit-subunit interactions. Biochemistry 37, 2401-2409.
3. Devidas, S., and Guggino, W. B. (1997) The cystic fibrosis transmembrane conductance regulator and ATP. [Review] [53 refs]. Curr. Opin. Cell Biol. 9, 547-552.
4. Yike, I., Ye, J., Zhang, Y., Manavalan, P., Gerken, T. A., and Dearborn, D. G. (1996) A recombinant peptide model of the first nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator: Comparison of wild-type and delta F508 mutant forms. Protein Sci. 5, 89-97.
5. Logan, J., Hiestand, D., Daram, P., Huang, Z., Muccio, D. D., Hartman, J., Haley, B, Cook, W. J., and Sorscher, E. J. (1994) Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding. J. Clin. Invest. 94, 228-236.
6. Arispe, N., Rojas, E., Hartman, J., Sorscher, E. J., and Pollard, H. B. (1992) Intrinsic anion channel activity of the recombinant first nucleotide binding fold domain of the cystic fibrosis transmembrane regulator protein. Proc. Natl. Acad. Sci. USA 89, 1539-1543.
7. Hartman, J., Huang, Z., Rado, T. A., Peng, S., Jilling, T., Muccio, D. D., and Sorscher, E. J. (1992) Recombinant synthesis, purification, and nucleotide binding characteristics of the first nucleotide binding domain of the cystic fibrosis gene product. J. Biol. Chem. 267, 6455-6458.
8. Ko, Y. H., and Pedersen, P. L. (1995). The first nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator can function as an active ATPase. J. Biol. Chem. 270, 22093-22096.
9. Gadsby, D. C., and Nairn, A. C. (1999) Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis. Physiol Rev. 79, S77-S106.
10. Bianchet, M. A., Ko, Y. H., Amzel, L. M., and Pedersen, P. L. (1997) Modeling of nucleotide binding domains of ABC transporter proteins based on a F1-ATPase/recA topology: Structural model of the nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator (CFTR). J. Bioenerg. Biomembr. 29, 503-524.
11. Delepelaire, P. (1994) PrtD, the integral membrane ATP-binding cassette component of the Erwinia chrysanthemi metalloprotease secretion system, exhibits a secretion signal-regulated ATPase activity. J. Biol. Cheistry. 269, 27952-27957.
12. Koronakis, V., Hughes, C., and Koronakis, E. (1993) ATPase activity and ATP/ADP-induced conformational change in the soluble domain of the bacterial protein translocator H1yB. Mol. Microbiol. 8, 1163-1175.
13. Schultz, B. D., Bridges, R. J., and Frizzell, R. A. (1996) Lack of conventional ATPase properties in CFTR chloride channel gating. J. Membr. Biol. 151, 63-75.
14. Hwang, T. C., Nagel, G., Nairn, A. C., and Gadsby, D. C. (1994) Regulation of the gating of cystic fibrosis transmembrane conductance regulator Cl channels by phosphorylation and ATP hydrolysis. Proc. Natl. Acad. Sci. USA 91, 4698-4702.
15. Gadsby, D. C., and Nairn, A. C. (1994) Regulation of CFTR channel gating. Trends Biochem. Sci. 19, 513-518.
16. - channel gating to an ATP hydrolysis cycle. Neuron 12, 473-482.
17. Yang, Y., Devor, D. C., Engelhardt, J. F., Ernst, S. A., Strong, T. V., Collins, F. S., Cohn, J. A., Frizzell, R. A., and Wilson, J. M. (1993) Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR. Hum. Mol. Genet. 2, 1253-1261.
18. Gregory, R. J., Rich, D. P., Cheng, S. H., Souza, D. W., Paul, S., Manavalan, P., Anderson, M. P., Welsh, M. J., and Smith, A. E. (1991) Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol. Cell. Biol. 11, 3886-3893.
19. Welsh, M. J., and Smith, A. E. (1993) Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. [Review] [26 refs]. Cell 73, 1251-1254.
20. Tsui, L. C. (1991) Probing the basic defect in cystic fibrosis. [Review] [39 refs]. Curr. Opin. Genet. Dev. 1, 4-10.
21. Anderson, M. P., and Welsh, M. J. (1992) Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains [published erratum appears in Science (1992) 258(5089), 1719]. Science 257, 1701-1704.
22. Hyde, S. C., Emsley, P., Hartshorn, M. J., Mimmack, M. M., Gileadi, U., Pearce, S. R., Gallagher, M. P., Gill, D. R., Hubbard, R. E., and Higgins, C. F. (1990) Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport [see comments]. Nature 346, 362-365.
23. Jones, P. M., and George, A. M. (1999) Subunit interactions in ABC transporters: Towards a functional architecture [in press citation]. FEMS Microbiol. Lett. 179, 187-202.
24. Shacter, E. (1984) Organic extraction of Pi with isobutanol/ toluene. Anal. Biochem. 138, 416-420.
25. Nelson, N. (1980) Organic extraction of inorganic phosphate. Methods Enzymol. 69, 301-313.
26. Randak, C., Auerswald, E. A., Assfalg-Machleidt, I., Reenstra, W. W., and Machleidt, W. (1999) Inhibition of ATPase, GTPase and adenylate kinase activities of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator by genistein. Biochem, J. 340, 227-235.
27. Weinreich, F., Wood, P. G., Riordan, J. R., and Nagel, G. (1997) Direct action of genistein on CFTR. Pflugers Arch. Eur. J. Physiol. 434, 484-491.
28. Illek, B., Fischer, H., Santos, G. F., Widdicombe, J. H., Machen, T. E., and Reenstra, W. W. (1995) cAMP-independent activation of CFTR Cl channels by the tyrosine kinase inhibitor genistein. Am. J. Physiol. 268, C886-893.
29. Hwang, T. C., Wang, F., Yang, I. C., and Reenstra, W. W. (1997) Genistein potentiates wild-type and delta F508-CFTR channel activity. Am. J. Physiol. 273, C988-998.
30. Mohamed, A., Ferguson, D., Seibert, F. S., Cai, H. M., Kartner, N., Grinstein, S., Riordan, J. R., and Lukacs, G. L. (1997) Functional expression and apical localization of the cystic fibrosis transmembrane conductance regulator in MDCK I cells. Biochem. J. 322, 259-265.
31. Benharouga, M., Fritsch, J., Banting, G., and Edelman, A. (1997) Properties of chloride-conductive pathways in rat kidney cortical and outer-medulla brush-border membranes - Inhibition by anti-(cystic fibrosis transmembrane regulator) mAbs. Eur. J. Biochem. 246, 367-372.
32. Mitchell, C. H., Carre, D. A., McGlinn, A. M., Stone, R. A., and Civan, M. M. (1998) A release mechanism for stored ATP in ocular ciliary epithelial cells. Proc. Natl. Acad. Sci. USA 95, 7174-7178.
33. Nguyen, T. D., Canada, A. T., Heintz, G. G., Gettys, T. W., and Cohn, J. A. (1991) Stimulation of secretion by the T84 colonic epithelial cell line with dietary flavonols. Biochem. Pharmacol. 41, 1879-1886.
34. Kolarov, J., Kulpa, J., Baijot, M., and Goffeau, A. (1988) Characterization of a protein serine kinase from yeast plasma membrane. J. Biol. Chem.. 263, 10613-10619.
35. - channels expressed in a mammalian cell line and its regulation by a critical pore residue. J. Physiol. 496, 687-693.
36. Fitz, J. G., Basavappa, S., McGill, J., Melhus, O., and Cohn, J. A. (1993) Regulation of membrane chloride currents in rat bile duct epithelial cells. J. Clin. Invest. 91, 319-328.
37. al-Nakkash, L., and Hwang, T. C. (1999) Activation of wild-type and deltaF508-CFTR by phosphodiesterase inhibitors through cAMP-dependent and -independent mechanisms. Pflugers Arch. Eur. J. Physiol. 437, 553-561.
38. - secretion in G551D cystic fibrosis mutant mice. Am. J. Physiol. 274, C492-9.
39. Smith, S. N., Middleton, P. G., Chadwick, S., Jaffe, A., Bush, K. A., Rolleston, S., Farley, R., Delaney, S. J., Wainwright, B., Geddes, D. M., and Alton, E. W. (1999) The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects. Am. J. Respir. Cell Mol. Biol. 20, 129-134.
40. Lee, G., Huang, Z., Wang, Y., Sorscher, E., Jacobson, K. A., Barnoy, S., and Pollard, H. B. (1995) CPX control of calcium-dependent aggregation of biological membranes and acidic phospholipid liposomes driven by nucleotide binding fold-1 (NBF1) domain from CFTR. Pediatr. Pulmonol. S12, 185-185.
41. Lee, G., Cohen, B. E., Barnoy, S., Eidelman, O., Jacobson, K. A., and Pollard, H. B. (1998) CPX binds to 30 residue peptide domain I-alpha (CFTR[477-508]) from first nucleotide binding fold, and potentiates peptide-membrane interactions. Pediatr. Pulmonol. Suppl. S12, 185-185.
42. - secretion. J. Clin. Invest. 102, 679-687.
43. - conductance. J. Biol. Chem. 269, 8667-8674.
44. Armstrong, S., Tabernero, H., Zhang, H., Hermodson, M., and Stauffacher, C. (1998) Powering the ABC transporter. Pediatr. Pulmonol. Suppl. 17, 91-92.
45. Hung, L-W., Wang, I. X., Nikaido, K., Liu, P-Q., Ames, G. F., and Kim, S-H. (1998) Crystal structure of the ATP-binding subunit of an ABC transporter. Nature 396, 703-707.
46. Ko, Y. H., and Pedersen, P. L. (1997) Frontiers in research on cystic fibrosis: understanding its molecular and chemical basis and relationship to the pathogenesis of the disease. [Review] [101 refs]. J. Bioenerg. Biomembr. 29, 417-427.
47. Urbatsch, I. L., al-Shawi, M. K., and Senior, A. E. (1994) Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein. Biochemistry 33, 7069-7076.
48. Braun, J., Arnemann, J., Lohrey, M., Donner, H., Siegmund, T., Usadel, K. H., and Badenhoop, K. (1999) No association between the deltaF508 cystic fibrosis mutation and type 2 diabetes mellitus [in press citation]. Exp. Clin. Endocrinol. Diabetes 107, 568-569.
49. Szabo, K., Szakacs, G., Hegeds, T., and Sarkadi, B. (1999) Nucleotide occlusion in the human cystic fibrosis transmembrane conductance regulator. Different patterns in the two nucleotide binding domains. J. Biol. Chem. 274, 12209-12212.
50. Cohen, B. E., Lee, G., Jacobson, K. A., Kim, Y. C., Huang, Z., Sorscher, E. J., and Pollard, H. B. (1997) 8-Cyclopentyl-1,3-dipropylxanthine and other xanthines differentially bind to the wild-type and delta F508 first nucleotide binding fold (NBF-1) domains of the cystic fibrosis transmembrane conductance regulator. Biochemistry 36, 6455-6461.
51. Ames, G. F., Mimura, C., Holbrook, S., and Shyamala, V. (1992) Traffic ATPases: a superfamily of transport proteins operating from Escherichia coli to humans. Adv. Enzymol. 65, 1-47.
52. Smit, L. S., Wilkinson, D. J., Mansoura, M. K., Collins, F. S., and Dawson, D. C. (1993). Functional roles of the nucleotide-binding folds in the activation of the cystic fibrosis transmembrane conductance regulator. Proc. Natl. Acad. Sci. USA 90, 9963-9967.
53. Li, C., Ramjeesingh, M., Wang, W., Garami, E., Hewryk, M., Lee, D., Rommens, J. M., Galley, K., and Bear, C. E. (1996). ATPase activity of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 271, 28463-28468.